Immuno-modulation in Amyotrophic Lateral Sclerosis: a phase II study of safety and activity of low dose Interleukin-2

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/201630/06/2017

Funding

  • Nimes University Hospital Centre: £24,714.00